CRRX CareRx Corp
- 1.930
- +0.050+2.66%
CareRx Corp News
CareRx Q3 Net Loss Narrows on Lower Finance Costs, Cost-Saving Moves
CareRx Corp (CHHHF) Q2 2024 Earnings Call Highlights: Operational Efficiency Boosts Adjusted ...
CareRx Brief: Consolidating Its Existing Burnaby and Vancouver Pharmacy Operations Into the New North Burnaby Location, Starting Early December 2024
CareRx Brief: Says Opening State-of-the-Art Pharmacy in British Columbia
Earnings Flash: CareRx Q2 Diluted EPS $0.13, Up From $0.11 in 2023
CareRx Corp. Is Maintained at Buy by Desjardins Securities
CareRx Corp. Price Target Raised to C$4.00/Share From C$3.75 by Desjardins Securities
CareRx Brief: Dalton Will Be Succeeded by Jeff Watson, a Current Independent Director of the Board
CareRx Brief: Company Undertaking a Search for a New CFO; Davide Pernarella, Currently Vice President, Business Planning and Analysis at CareRx, Will Assume the Role of Interim CFO
CareRx Brief: Says Andrew Mok Will Step Down as Chief Financial Officer Effective June 7, 2024, to Pursue Another Employment Opportunity
CareRx Q1 Net Loss Narrows, Revenue Dips
Calendar of Canada Earnings Expected in the Week Ahead
CareRx Corporation to Host First Quarter 2024 Financial Results Conference Call on Friday, May 10, 2024 at 8:30 A.m. ET
CareRX Corp. Is Maintained at Buy by Desjardins Securities
CareRx to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 17, 2024
CareRx Corporation Welcomes Ontario Government's Pause of Planned Fee Changes
CareRx Brief: In Connection With Prior Announced Normal Course Issuer Bid to Buy Up To 1 Million of Its Common Shares, It Has Entered Into an Automatic Share Purchase Plan
Carerx Corp Price Target Cut to C$2.75/Share From C$3.25 by Stifel Nicolaus
CareRx Narrows Q4 Loss, Revenue Falls
CareRx Corp: MDA EN
No Data